| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.64B | 5.27B | 5.07B | 1.66B | 739.00M |
| Gross Profit | 101.53M | 335.10M | 1.21B | -368.60M | -507.20M |
| EBITDA | 1.31B | 1.24B | 1.29B | -105.70M | -143.20M |
| Net Income | 2.18M | 225.80M | 376.60M | -631.80M | -572.10M |
Balance Sheet | |||||
| Total Assets | 11.28B | 9.64B | 8.69B | 5.36B | 4.72B |
| Cash, Cash Equivalents and Short-Term Investments | 1.91B | 1.66B | 1.48B | 1.22B | 1.45B |
| Total Debt | 6.99B | 6.61B | 6.27B | 3.96B | 3.14B |
| Total Liabilities | 10.35B | 9.32B | 8.55B | 5.09B | 3.82B |
| Stockholders Equity | 932.98M | 366.60M | 183.40M | 279.30M | 907.80M |
Cash Flow | |||||
| Free Cash Flow | 591.36M | 420.10M | -32.10M | -218.00M | -263.20M |
| Operating Cash Flow | 1.24B | 1.07B | 676.80M | 421.90M | 281.20M |
| Investing Cash Flow | 694.38M | -263.40M | -360.00M | 532.90M | -317.80M |
| Financing Cash Flow | -1.43B | -938.70M | -1.02B | -311.20M | -325.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £20.56B | 5.07 | 75.17% | 2.07% | 4.84% | 30.33% | |
74 Outperform | £3.85B | 9.27 | 11.57% | 2.37% | 9.93% | 1.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | £1.23B | 8.05 | 30.56% | ― | 10.71% | -101.29% |